Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Operating Expenses: 2017-2024

Historic Operating Expenses for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to $26.7 million.

  • DiaMedica Therapeutics' Operating Expenses rose 30.85% to $2.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $11.6 million, marking a year-over-year increase of 59.68%. This contributed to the annual value of $26.7 million for FY2024, which is 25.46% up from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Operating Expenses of $26.7 million as of FY2024, which was up 25.46% from $21.3 million recorded in FY2023.
  • In the past 5 years, DiaMedica Therapeutics' Operating Expenses ranged from a high of $26.7 million in FY2024 and a low of $12.7 million during FY2020.
  • For the 3-year period, DiaMedica Therapeutics' Operating Expenses averaged around $20.6 million, with its median value being $21.3 million (2023).
  • Data for DiaMedica Therapeutics' Operating Expenses shows a peak YoY spiked of 51.90% (in 2023) over the last 5 years.
  • DiaMedica Therapeutics' Operating Expenses (Yearly) stood at $12.7 million in 2020, then grew by 7.46% to $13.6 million in 2021, then rose by 2.60% to $14.0 million in 2022, then skyrocketed by 51.90% to $21.3 million in 2023, then increased by 25.46% to $26.7 million in 2024.